Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan for Exercise-Induced PAH in Scleroderma
NCT00377455Phase 2Terminated
- Sponsor
- Georgetown University
- Start
- Sep 2006
- Primary completion
- Sep 2009
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bosentan in pulmonary hypertension (PH), sponsored by Georgetown University. Started Sep 2006; status: terminated.
02
Drugs
bosentan
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT00377455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00377455.